Delayed osteoblast differentiation and altered inflammatory response around implants placed in incisor sockets of type 2 diabetic rats

Clinical Oral Implants Research

Volumn 22, Issue 6, 2011, Pages 578-586

  Colombo, John S ^a   Balani, Deepak ^a   Sloan, Alastair J ^a   Crean, St John ^b   Okazaki, Joji ^c   Waddington, Rachel J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

IL 1 ; Macrophages; Osteoblast; Osteocalcin; Osteopontin; TGF ; TNF ; Type 2 diabetes

Indexed keywords

AUTACOID; CYCLINE; INTERLEUKIN 1BETA; MEMBRANE ANTIGEN; OSTEOCALCIN; OSTEOPONTIN; SPP1 PROTEIN, RAT; STRO 1 ANTIGEN, RAT; STRO-1 ANTIGEN, RAT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; IMAGE PROCESSING; INCISOR; MACROPHAGE; MALE; MANDIBLE; MESENCHYMAL STEM CELL; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOBLAST; PATHOLOGY; PHYSIOLOGY; RAT; TOOTH IMPLANTATION; TOOTH SOCKET; WISTAR RAT; WOUND HEALING;

ANIMALS; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DENTAL IMPLANTS; DIABETES MELLITUS, TYPE 2; IMAGE PROCESSING, COMPUTER-ASSISTED; INCISOR; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MANDIBLE; MESENCHYMAL STEM CELLS; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; TOOTH SOCKET; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 79955783758     PISSN: 09057161     EISSN: 16000501     Source Type: Journal    
DOI: 10.1111/j.1600-0501.2010.01992.x     Document Type: Article

References (48)

1. Borst, S.E. (2004) The role of TNF-alpha in insulin resistance. Endocrine 23: 177-182.
2. Boskey, A.L, Gadaleta, S., Gundberg, C., Doty, S.B., Ducy, P. & Karsenty, G. (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23: 187-196.
3. Casap, N., Nimri, S., Ziv, E., Sela, J. & Samuni, Y. (2008) Type 2 diabetes has minimal effect on osseointegration of titanium implants in Psammomys obesus. Clinical Oral Implants Research 19: 458-464.
4. Centralla, M., Horowitz, M.C., Wozney, J.M. & McCarthy, T.L. (1994) Transforming growth factor-β gene family members and bone. Endocrine Reviews 15: 27-29.
5. Davies, J.E. (2003) Understanding peri-implant endosseous healing. Journal of Dental Education 67: 932-949.
6. Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D. & Berman, J.S. (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. The Journal of Clinical Investigation 107: 1055-1061.
7. Devaraj, S., Venugopal, S.K., Singh, U. & Jialal, I. (2005) Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-alpha and -beta. Diabetes 54: 85-91.
8. Dinarello, C.A. (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Reviews of Immunology 16: 457-499.
9. Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., Bradley, A. & Karsenty, G. (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382: 448-452.
10. Ellies, L.G. & Aubin, J.E. (1990) Temporal sequence of interleukin 1 alpha-mediated stimulation and inhibition of bone formation by isolated fetal rat calvaria cells in vitro. Cytokine 2: 430-437.
11. El-seweidy, M.M., El-Swefy, S.E., Ameen, R.S. & Hashem, R.M. (2002) Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats. Pharmacological Research 45: 391-398.
12. Gebauer, G.P., Lin, S.S, Beam, H.A., Vieira, P. & Parsons, J.R. (2002) Low-intensity pulsed ultrasound increases the fracture callus strength in diabetic BB Wistar rats but does not affect cellular proliferation. Journal of Orthopaedic Research 20: 587-592.
13. Goodman, W. & Hori, M. (1984) Diminished bone formation in experimental diabetes. Relationship to osteoid maduration and mineralization. Diabetes 33: 825-831.
14. Gorski, J.P. (1992) Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calcified Tissue International 50: 391-396.
15. Goto, Y., Kakizaki, M. & Masaki, N. (1975) Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proceedings of the Japan Academy 51: 80-85.
16. Gowen, M., MacDonald, B.R. & Russell, R.G. (1988) Actions of recombinant human gamma-interferon and tumor necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis and Rheumatism 31: 1500-1507.
17. Hanazawa, S., Ohmori, Y., Amano, S., Hirose, K., Miyoshi, T., Kumegawa, M. & Kitano, S. (1986) Human purified interleukin-1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3-E1), but enhances alkaline phosphatase activity in the cells. FEBS Letters 203: 279-284.
18. Hasegawa, H., Ozawa, S., Hashimoto, K., Takeichi, T. & Ogawa, T. (2008) Type 2 diabetes impairs implant osseointegration capacity in rats. The International Journal of Oral & Maxillofacial Implants 23: 237-246.
19. He, H., Liu, R., Desta, T., Leone, C., Gerstenfeld, L.C. & Graves, D.T. (2004) Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 145: 447-452.
20. Hughes, F.J., Turner, W., Belibasakis, G. & Martuscelli, G. (2006) Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000 41: 48-72.
21. Kopman, J.A., Kim, D.M., Rahman, S.S., Arandia, J.A., Karimbux, N.Y. & Fiorellini, J.P. (2005) Modulating the effects of diabetes on osseointegration with aminoguanidine and doxycycline. Journal of Periodontology 76: 614-620.
22. Kwon, P.T., Rahman, S.S., Kim, D.M., Kopman, J.A., Karimbux, N.Y. & Fiorellini, J.P. (2005) Maintenance of osseointegration utilizing insulin therapy in a diabetic rat model. Journal of Periodontology 76: 621-626.
23. Lerner, U.H. (2006) Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. Journal of Dental Research 85: 596-607.
24. Liu, Z., Aronson, J., Wahl, E.C., Liu, L., Perrien, D.S., Kern, P.A., Fowlkes, J.L., Thrailkill, K.M., Bunn, R.C., Cockrell, G.E., Skinner, R.A. & Lumpkin, C.K. Jr. (2007) A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthopaedica 78: 46-55.
25. Maeda, S., Hayashi, M., Komiya, S., Imamura, T. & Miyazono, K. (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO Journal 23: 552-563.
26. McCracken, M., Lemons, J.E., Rahemtulla, F., Prince, C.W. & Feldman, D. (2000) Bone response to titanium alloy implants placed in diabetic rats. The International Journal of Oral & Maxillofacial Implants 15: 345-354.
27. McCracken, M.S., Aponte-Wesson, R., Chavali, R. & Lemons, J.E. (2006) Bone associated with implants in diabetic and insulin-treated rats. Clinical Oral Implants Research 17: 495-500.
28. Nanes, M.S. (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15.
29. Neumann, A., Schinzel, R., Palm, D., Riederer, P. & Munch, G. (1999) High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Letters 453: 283-287.
30. Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E.B., Jones, K.L., Kawamori, R., Cassis, L.A., Tschöp, M.H. & Bruemmer, D. (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. Journal of Clinical Investigation 117: 2877-2888.
31. Ohmori, Y., Hanazawa, S., Amano, S., Hirose, K., Kumegawa, M. & Kitano, S. (1988) Effects of recombinant human interleukin 1 alpha and interleukin 1 beta on cell growth and alkaline phosphatase of the mouse osteoblastic cell line MC3T3-E1. Biochimica et Biophysica Acta 970: 22-30.
32. Reinholt, F.P., Hultenby, K., Oldberg, A. & Heinegård, D. (1990) Osteopontin - a possible anchor of osteoclasts to bone. Proceedings of the National Academy of Science USA 87: 4473-4475.
33. Sakai, D., Okazaki, J. & Komasa, Y. (2008) Bone healing of tooth extraction socket in type 2 diabetes. Journal of Oral Tissue Engineering 5: 134-144.
34. Santana, R.B., Xu, L., Babakhanlou, C., Amar, S., Graves, D.T. & Trackman, P.C. (2003) A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52: 1502-1510.
35. Schmidt, A.M. & Stern, D.M. (2000) RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends in Endocrinology and Metabolism 11: 368-375.
36. Senn, J.J., Klover, P.J., Nowak, I.A. & Mooney, R.A. (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51: 3391-3399.
37. Shi, S., Bartold, P.M., Miura, M., Seo, B.M., Robey, P.G. & Gronthos, S. (2005) The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthodontics and Craniofacial Research 8: 191-199.
38. Shires, R., Teitelbaum, S.L., Bergfeld, M.A., Fallon, M.D., Slatopolsky, E. & Avioli, L.V. (1981) The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. Journal of Laboratory and Clinical Medicine 97: 231-240.
39. Shyng, Y.C., Devlin, H. & Ou, K.L. (2006) Bone formation around immediately placed oral implants in diabetic rats. International Journal of Prosthodontics 19: 513-514.
40. Siqueira, J.T., Cavalher-Machado, S.C., Arana-Chavez, V.E. & Sannomiva, P. (2003) Bone formation around titanium implants in the rat tibia: role of insulin. Implant Dentistry 12: 242-251.
41. Sodek, J., Batista Da Silva, A.P. & Zohar, R. (2006) Osteopontin and mucosal protection. Journal of Dental Research 85: 404-415.
42. Tuominen, J.T., Impivaara, O., Puukka, P. & Ronnemaa, T. (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22: 1196-1200.
43. Tyndall, W.A., Beam, H.A., Zarro, C., O'Connor, J.P. & Lin, S.S. (2003) Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clinical Orthopaedics and Related Research 408: 319-330.
44. Valero, A.M., García, J.C.F., Ballester, A.H. & Rueda, C.L. (2007) Effects of diabetes on the osseointegration of dental implants. Medicina Oral, Patología Oral y Cirugía Bucal 12: E38-E43.
45. Verhaeghe, J., Suiker, A.M., Nyomba, B.L., Visser, W.J., Einhorn, T.A., Dequeker, J. & Bouillon, R. (1989) Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124: 573-582.
46. Vlassara, H. & Palace, M.R. (2002) Diabetes and advanced glycation endproducts. Journal of Internal Medicine 251: 87-101.
47. Wang, K.X. & Denhardt, D.T. (2008) Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Reviews 19: 333-345.
48. Wilmer, W.A., Dixon, C.L. & Hebert, C. (2001) Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney International 60: 858-871.